[Genetic abnormality in cervical cancer].
Umayahara
Kenji
K
Department of Gynecology, Cancer Institute Hospital.
D017766:Acid Anhydride Hydrolases / Q000235:genetics; D002869:Chromosome Aberrations; D058534:Class I Phosphatidylinositol 3-Kinases; D005260:Female; D020868:Gene Silencing; D016161:Genes, Retinoblastoma / Q000235:genetics; D016147:Genes, Tumor Suppressor; D016158:Genes, p53 / Q000235:genetics; D006801:Humans; D009363:Neoplasm Proteins / Q000235:genetics; D009856:Oncogene Proteins, Viral / Q000502:physiology; D009857:Oncogenes; D027383:Papillomaviridae / Q000235:genetics; D030361:Papillomavirus Infections; D019869:Phosphatidylinositol 3-Kinases / Q000235:genetics; D025521:Tumor Suppressor Proteins / Q000235:genetics; D002583:Uterine Cervical Neoplasms / Q000235:genetics*; D000099170:Bis(5'-adenosyl)triphosphatase
D017766:Acid Anhydride Hydrolases; D058534:Class I Phosphatidylinositol 3-Kinases; D009363:Neoplasm Proteins; D009856:Oncogene Proteins, Viral; D019869:Phosphatidylinositol 3-Kinases; D025521:Tumor Suppressor Proteins; D000099170:Bis(5'-adenosyl)triphosphatase; C411762:RASSF1 protein, human; C484760:PIK3CA protein, human